Respiratory diseases are increasingly gaining in significance (allergies, environment-related asthma, smoking, etc.). For the Chiesi Group, the products for treating pulmonary diseases represent the most important point of focus in development and marketing. In particular, Chiesi has patented metered-dose inhalers based on CFC-free technology (Modulite® Technology). The group’s own product range has been supplemented by Prolastin®, a medicine for a rare genetic disease (Alpha-1-antitrypsin deficiency).

Active ingredients

Beclomethasone dipropionate + formoterol fumarate dihydrate

Trade name: Foster®

Administration: Pressurised inhalation, solution (metered-dose inhaler)

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (AGES Medicines & Medical Devices – Austrian Federal Office for Safety in Health Care) or consult your doctor or pharmacist.

Beclomethasone dipropionate + formoterol fumarate dihydrate

Trade name: Foster® NEXThaler®

Administration: Inhalation powder (dry powder)

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (AGES Medicines & Medical Devices – Austrian Federal Office for Safety in Health Care) or consult your doctor or pharmacist.

Beclomethasone dipropionate + formoterol fumarate dihydrate + glycopyrronium

Trade name: Trimbow®

Administration: Pressurised inhalation, solution (metered-dose inhaler)

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (EMA - European Medicines agency ) or consult your doctor or pharmacist.

Budesonide

Trade name: Budiair®

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (AGES Medicines & Medical Devices – Austrian Federal Office for Safety in Health Care) or consult your doctor or pharmacist.

Formoterol fumarate dihydrate

Trade name: Forair®

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (AGES Medicines & Medical Devices – Austrian Federal Office for Safety in Health Care) or consult your doctor or pharmacist.

Levofloxacin

Trade name: Quinsair®

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (EMA - European Medicines agency ) or consult your doctor or pharmacist.

Tobramycin

Trade name: Bramitob®

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (AGES Medicines & Medical Devices – Austrian Federal Office for Safety in Health Care) or consult your doctor or pharmacist.

Alpha-1-Proteinase-Inhibitor

Trade name: Prolastin®

For interested parties from Austria: For more detailed information, please refer to the published patient information leaflet (AGES Medicines & Medical Devices – Austrian Federal Office for Safety in Health Care) or consult your doctor or pharmacist.